Market Overview:
The global thapsigargin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing R&D investments for novel drug discovery, and growing demand for thapsigargin in research and medical applications. However, the high cost of production is expected to restrain the growth of the market during the forecast period. The global thapsigargin market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. On the basis of application, it can be classified into research and medical applications. The research application segment is expected to account for a larger share in terms of revenue in 2018 owing to rising R&D investments for novel drug discovery across different regions worldwide.
Product Definition:
Thapsigargin is a natural product isolated from the plant Thapsia garganica. It is a powerful and specific inhibitor of the enzyme sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), which regulates intracellular calcium levels. This makes thapsigargin useful for studying the role of calcium in various cellular processes. Additionally, thapsigargin can be used to induce apoptosis (programmed cell death) in cancer cells, making it a potential therapeutic agent for cancer treatment.
Min Purity Less Than 98%:
Thapsigargin is a naturally occurring compound extracted from the leaves of thapsia garganica, a plant endemic to the island of Réunion in the Indian Ocean. It was first identified and characterized in 1982 by French researchers at the Laboratory of Biochemistry and Molecular Biology (LFCB) who named it after its discoverer. The compound has been found to exhibit antifungal properties against several pathogenic fungi including Aspergillus flavus, A.
Min Purity 98%-99%:
Min Purity 98%-99% is a product that contains very small amount of impurities (less than 0.5%) on a dry weight basis. It's main application is in the synthesis of thapsigargin, which has high demand from pharmaceutical and agrochemical industries due to its property to protect plants against various pathogens and bacteria.
Application Insights:
The research application segment held the largest share of over 70.0% in 2017. The product is used as a tool for studying protein kinases and their substrates, which are involved in various physiological processes such as cell proliferation, apoptosis, migration and invasion. It has been found to be an effective inhibitor of protein kinase C (PKC) activity with high specificity towards g-secretase1/2 substrate proteins; it does not inhibit other PKC isotypes or non-specifically bind to other proteins such as Raf or Erk that also bind specifically to their respective substrates. This property makes it suitable for use in research applications where specificity and efficacy are key requirements.
Regional Analysis:
North America accounted for the largest share of over 35.0% in 2017. The region is expected to maintain its dominance during the forecast period owing to increasing R&D activities and high healthcare expenditure in U.S., which is one of the major factors contributing towards market growth in this region. Asia Pacific is anticipated to be the fastest-growing regional market from 2018 to 2030 due to rising product demand from emerging countries, such as China, India, and South Korea among others.
Europe was valued at USD X million in 2017.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the thapsigargin market. According to the American Cancer Society, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S., and approximately 600,920 people died from this disease. This number is expected to rise in future due to increase in aging population and lifestyle-related diseases such as obesity and smoking.
- Rising demand for novel anticancer therapies: The rising demand for novel anticancer therapies is another key growth driver for the thapsigargin market. Thapsigargin has been shown to be effective against a range of cancers including breast cancer, ovarian cancer, prostate cancer, pancreatic ductal adenocarcinoma (PDA), colorectal carcinoma (CRC), non-small cell lung carcinoma (NSCLC), melanoma etc., which has led to its increasing adoption by oncologists worldwide.
- Growing investment in R&D activities: The growing investment in R&D activities by pharmaceutical companies is also propelling the growth of thapsigargin market globally. For instance, Incyte Corporation announced an investment totaling billion over 10 years into its research and development efforts with a focus on developing innovative treatments for patients with unmet medical needs across multiple therapeutic areas including oncology and inflammation/immunology diseases at ASCO Annual Meeting
Scope Of The Report
Report Attributes
Report Details
Report Title
Thapsigargin Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Cell Signaling Technology, Bio-Techne, Thermo Fisher Scientific, Santa Cruz Biotechnology, Enzo Biochem, AG Scientific, Cayman Chemical, Merck, Hello Bio, Selleck Chemicals, Abcam, Focus Biomolecules, PromoCell, Aladdin, Beyotime
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Thapsigargin Market Report Segments:
The global Thapsigargin market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cell Signaling Technology
- Bio-Techne
- Thermo Fisher Scientific
- Santa Cruz Biotechnology
- Enzo Biochem
- AG Scientific
- Cayman Chemical
- Merck
- Hello Bio
- Selleck Chemicals
- Abcam
- Focus Biomolecules
- PromoCell
- Aladdin
- Beyotime
Highlights of The Thapsigargin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Thapsigargin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Thapsigargin is a peptide that inhibits the enzyme thapsigargin.
Some of the major companies in the thapsigargin market are Cell Signaling Technology, Bio-Techne, Thermo Fisher Scientific, Santa Cruz Biotechnology, Enzo Biochem, AG Scientific, Cayman Chemical, Merck, Hello Bio, Selleck Chemicals, Abcam, Focus Biomolecules, PromoCell, Aladdin, Beyotime.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Thapsigargin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Thapsigargin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Thapsigargin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Thapsigargin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Thapsigargin Market Size & Forecast, 2020-2028
4.5.1 Thapsigargin Market Size and Y-o-Y Growth
4.5.2 Thapsigargin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Thapsigargin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Thapsigargin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Thapsigargin Market: Competitive Dashboard
14.2 Global Thapsigargin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cell Signaling Technology
14.3.2 Bio-Techne
14.3.3 Thermo Fisher Scientific
14.3.4 Santa Cruz Biotechnology
14.3.5 Enzo Biochem
14.3.6 AG Scientific
14.3.7 Cayman Chemical
14.3.8 Merck
14.3.9 Hello Bio
14.3.10 Selleck Chemicals
14.3.11 Abcam
14.3.12 Focus Biomolecules
14.3.13 PromoCell
14.3.14 Aladdin
14.3.15 Beyotime
